US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 17.000
  • -0.360-2.07%
Close Sep 27 16:00 ET
  • 17.000
  • 0.0000.00%
Post 16:02 ET
363.59MMarket Cap-360P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-45.99%-14.45M
-81.60%-15.92M
-61.74%-51.16M
-96.52%-23.29M
-311.69%-9.22M
19.36%-9.9M
26.12%-8.77M
47.62%-31.63M
62.34%-11.85M
140.51%4.35M
Net income from continuing operations
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
Operating gains losses
161.63%3.91M
43.42%5.85M
756.57%138.07M
1,157.92%143.38M
-146.60%-3.05M
-236.45%-6.34M
121.86%4.08M
-999.06%-21.03M
-50.66%-13.55M
1,204.56%6.54M
Depreciation and amortization
11.36%196K
-11.17%183K
-34.50%843K
12.86%272K
-46.00%189K
-48.99%176K
-41.31%206K
2.80%1.29M
-39.90%241K
3.24%350K
Deferred tax
----
----
---19M
----
----
----
----
--0
----
----
Other non cash items
-438.50%-1.9M
4,790.91%39.81M
795.59%20.51M
3,120.58%18.78M
-33.33%358K
13.56%561K
20.41%814K
7.46%2.29M
16.83%583K
9.82%537K
Change In working capital
-1,068.25%-32.08M
-213.69%-6.37M
108.23%4.97M
44.48%-3.91M
-101.45%-34K
111.07%3.31M
121.75%5.6M
-25.28%-60.38M
81.41%-7.04M
-53.05%2.35M
-Change in receivables
-1,488.72%-31.14M
315.89%4.48M
481.41%907K
26.65%-2.08M
-101.95%-333K
113.31%2.24M
-61.03%1.08M
105.80%156K
-9.38%-2.83M
1,395.97%17.07M
-Change in prepaid assets
43.23%1.2M
8,360.00%1.65M
-151.19%-1.27M
-144.50%-1.24M
-1,307.14%-845K
168.05%835K
-102.34%-20K
270.30%2.47M
394.90%2.78M
-96.96%70K
-Change in payables and accrued expense
-294.04%-1.73M
-53.06%-7.06M
-95.71%73K
-0.24%1.68M
320.60%2.12M
-74.35%890K
-85.59%-4.61M
18.02%1.7M
109.72%1.68M
-105.08%-961K
-Change in other working capital
37.00%-412K
-159.37%-5.44M
108.12%5.26M
73.77%-2.27M
92.94%-976K
95.73%-654K
134.06%9.16M
-42.23%-64.71M
49.26%-8.66M
20.41%-13.83M
Cash from discontinued investing activities
Operating cash flow
-45.99%-14.45M
-81.60%-15.92M
-61.74%-51.16M
-96.52%-23.29M
-311.69%-9.22M
19.36%-9.9M
26.12%-8.77M
47.62%-31.63M
62.34%-11.85M
140.51%4.35M
Investing cash flow
Cash flow from continuing investing activities
-13,125.00%-1.59M
-102.14%-602K
330.70%34.61M
18.36%6.5M
0
87.88%-12K
194.65%28.12M
12.47%-15M
-43.54%5.49M
-1,561.32%-29.94M
Net PPE purchase and sale
-13,125.00%-1.59M
-363.08%-602K
82.85%-206K
69.67%-64K
--0
87.88%-12K
71.43%-130K
-10.69%-1.2M
24.10%-211K
-165.85%-436K
Net business purchase and sale
----
----
--6.56M
----
----
----
----
--0
----
----
Net investment purchase and sale
--0
--0
304.72%28.25M
--0
--0
--0
182.54%28.25M
14.04%-13.8M
-43.00%5.7M
-1,701.04%-29.5M
Cash from discontinued investing activities
Investing cash flow
-13,125.00%-1.59M
-102.14%-602K
330.70%34.61M
18.36%6.5M
--0
87.88%-12K
194.65%28.12M
12.47%-15M
-43.54%5.49M
-1,561.32%-29.94M
Financing cash flow
Cash flow from continuing financing activities
104.64%120K
28,779.87%43.03M
-133.52%-13.15M
14.08M
-4,150.49%-24.79M
-107.01%-2.59M
-91.38%149K
-25.87%39.22M
0
-57.79%612K
Net issuance payments of debt
----
----
---27.46M
--0
---24.87M
----
----
--0
--0
--0
Net common stock issuance
----
----
-115.83%-6.17M
---6.17M
----
----
----
-24.98%38.98M
--0
-69.46%415K
Net preferred stock issuance
--0
--40M
--20.25M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--120K
1,934.23%3.03M
-33.04%231K
--0
-58.38%82K
--0
0.68%149K
-63.26%345K
--0
116.48%197K
Net other financing activities
----
----
----
----
----
----
----
---110K
--0
--0
Cash from discontinued financing activities
Financing cash flow
104.64%120K
28,779.87%43.03M
-133.52%-13.15M
--14.08M
-4,150.49%-24.79M
-107.01%-2.59M
-91.38%149K
-25.87%39.22M
--0
-57.79%612K
Net cash flow
Beginning cash position
-17.82%104.8M
-27.54%78.29M
-6.41%108.04M
-29.24%80.98M
-17.52%115M
11.07%127.53M
-6.41%108.04M
-17.58%115.44M
-1.36%114.44M
9.68%139.44M
Current changes in cash
-27.38%-15.91M
35.90%26.51M
-300.34%-29.7M
57.42%-2.71M
-36.17%-34M
-150.98%-12.49M
3,400.85%19.51M
69.88%-7.42M
-992.78%-6.36M
-125.01%-24.97M
Effect of exchange rate changes
150.00%14K
76.19%-5K
-365.00%-53K
135.56%16K
4.76%-20K
-124.35%-28K
27.59%-21K
766.67%20K
-650.00%-45K
-250.00%-21K
End cash Position
-22.70%88.9M
-17.82%104.8M
-27.54%78.29M
-27.54%78.29M
-29.24%80.98M
-17.52%115M
11.07%127.53M
-6.41%108.04M
-6.41%108.04M
-1.36%114.44M
Free cash flow
-61.84%-16.03M
-85.71%-16.52M
-56.45%-51.37M
-93.62%-23.35M
-335.26%-9.22M
19.91%-9.91M
27.79%-8.9M
46.59%-32.83M
62.00%-12.06M
135.90%3.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -45.99%-14.45M-81.60%-15.92M-61.74%-51.16M-96.52%-23.29M-311.69%-9.22M19.36%-9.9M26.12%-8.77M47.62%-31.63M62.34%-11.85M140.51%4.35M
Net income from continuing operations 221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M
Operating gains losses 161.63%3.91M43.42%5.85M756.57%138.07M1,157.92%143.38M-146.60%-3.05M-236.45%-6.34M121.86%4.08M-999.06%-21.03M-50.66%-13.55M1,204.56%6.54M
Depreciation and amortization 11.36%196K-11.17%183K-34.50%843K12.86%272K-46.00%189K-48.99%176K-41.31%206K2.80%1.29M-39.90%241K3.24%350K
Deferred tax -----------19M------------------0--------
Other non cash items -438.50%-1.9M4,790.91%39.81M795.59%20.51M3,120.58%18.78M-33.33%358K13.56%561K20.41%814K7.46%2.29M16.83%583K9.82%537K
Change In working capital -1,068.25%-32.08M-213.69%-6.37M108.23%4.97M44.48%-3.91M-101.45%-34K111.07%3.31M121.75%5.6M-25.28%-60.38M81.41%-7.04M-53.05%2.35M
-Change in receivables -1,488.72%-31.14M315.89%4.48M481.41%907K26.65%-2.08M-101.95%-333K113.31%2.24M-61.03%1.08M105.80%156K-9.38%-2.83M1,395.97%17.07M
-Change in prepaid assets 43.23%1.2M8,360.00%1.65M-151.19%-1.27M-144.50%-1.24M-1,307.14%-845K168.05%835K-102.34%-20K270.30%2.47M394.90%2.78M-96.96%70K
-Change in payables and accrued expense -294.04%-1.73M-53.06%-7.06M-95.71%73K-0.24%1.68M320.60%2.12M-74.35%890K-85.59%-4.61M18.02%1.7M109.72%1.68M-105.08%-961K
-Change in other working capital 37.00%-412K-159.37%-5.44M108.12%5.26M73.77%-2.27M92.94%-976K95.73%-654K134.06%9.16M-42.23%-64.71M49.26%-8.66M20.41%-13.83M
Cash from discontinued investing activities
Operating cash flow -45.99%-14.45M-81.60%-15.92M-61.74%-51.16M-96.52%-23.29M-311.69%-9.22M19.36%-9.9M26.12%-8.77M47.62%-31.63M62.34%-11.85M140.51%4.35M
Investing cash flow
Cash flow from continuing investing activities -13,125.00%-1.59M-102.14%-602K330.70%34.61M18.36%6.5M087.88%-12K194.65%28.12M12.47%-15M-43.54%5.49M-1,561.32%-29.94M
Net PPE purchase and sale -13,125.00%-1.59M-363.08%-602K82.85%-206K69.67%-64K--087.88%-12K71.43%-130K-10.69%-1.2M24.10%-211K-165.85%-436K
Net business purchase and sale ----------6.56M------------------0--------
Net investment purchase and sale --0--0304.72%28.25M--0--0--0182.54%28.25M14.04%-13.8M-43.00%5.7M-1,701.04%-29.5M
Cash from discontinued investing activities
Investing cash flow -13,125.00%-1.59M-102.14%-602K330.70%34.61M18.36%6.5M--087.88%-12K194.65%28.12M12.47%-15M-43.54%5.49M-1,561.32%-29.94M
Financing cash flow
Cash flow from continuing financing activities 104.64%120K28,779.87%43.03M-133.52%-13.15M14.08M-4,150.49%-24.79M-107.01%-2.59M-91.38%149K-25.87%39.22M0-57.79%612K
Net issuance payments of debt -----------27.46M--0---24.87M----------0--0--0
Net common stock issuance ---------115.83%-6.17M---6.17M-------------24.98%38.98M--0-69.46%415K
Net preferred stock issuance --0--40M--20.25M----------0--0--0--------
Proceeds from stock option exercised by employees --120K1,934.23%3.03M-33.04%231K--0-58.38%82K--00.68%149K-63.26%345K--0116.48%197K
Net other financing activities -------------------------------110K--0--0
Cash from discontinued financing activities
Financing cash flow 104.64%120K28,779.87%43.03M-133.52%-13.15M--14.08M-4,150.49%-24.79M-107.01%-2.59M-91.38%149K-25.87%39.22M--0-57.79%612K
Net cash flow
Beginning cash position -17.82%104.8M-27.54%78.29M-6.41%108.04M-29.24%80.98M-17.52%115M11.07%127.53M-6.41%108.04M-17.58%115.44M-1.36%114.44M9.68%139.44M
Current changes in cash -27.38%-15.91M35.90%26.51M-300.34%-29.7M57.42%-2.71M-36.17%-34M-150.98%-12.49M3,400.85%19.51M69.88%-7.42M-992.78%-6.36M-125.01%-24.97M
Effect of exchange rate changes 150.00%14K76.19%-5K-365.00%-53K135.56%16K4.76%-20K-124.35%-28K27.59%-21K766.67%20K-650.00%-45K-250.00%-21K
End cash Position -22.70%88.9M-17.82%104.8M-27.54%78.29M-27.54%78.29M-29.24%80.98M-17.52%115M11.07%127.53M-6.41%108.04M-6.41%108.04M-1.36%114.44M
Free cash flow -61.84%-16.03M-85.71%-16.52M-56.45%-51.37M-93.62%-23.35M-335.26%-9.22M19.91%-9.91M27.79%-8.9M46.59%-32.83M62.00%-12.06M135.90%3.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data